[1] Liu B, Zhang D, Dong C,et al. Correlation between hepatic venous pressure gradient and portal pressure gradient in patients with autoimmune cirrhotic portal hypertension and collateral branches of the hepatic vein. Hepatol Res, 2023, 53(11):1084-1095. [2] Wang Y, Zhang G, Mu X, et al. Diagnostic value of magnetic resonance elastography in cirrhotic portal hypertension. J Hepatol, 2020, 73(2):S532-S533. [3] 李嘉兴,伍丽霞,尹承龙,等.腹腔镜脾切除联合贲门周围血管离断术治疗肝硬化门静脉高压并发食管胃底静脉曲张患者疗效研究.实用肝脏病杂志, 2023, 26(2):258-261. [4] 段建文,余华军,叶海林,等.选择性脾胃区减断术治疗肝硬化门静脉高压症的临床价值分析.中华肝胆外科杂志, 2021, 27(7)::525-528. [5] Shin S, Suh DI, Ko JM, et al. Combined lung and liver transplantation for noncirrhotic portal hypertension with severe hepatopulmonary syndrome in a patient with dyskeratosis congenital. Pediatr Transplant, 2021, 25(2):e13802. [6] Madoff DC, Cornman-Homonoff J, Fortune BE, et al. Management of refractory ascites due to portal hypertension: current status. Radiology, 2021, 298(3):493-504. [7] 中华医学会肝病学分会.肝硬化诊治指南.中华肝脏病杂志, 2019, 27(11):846-865. [8] Deng Y, Jiang Y, Jiang T, et al. Evaluation of the efficacy and safety of endoscopic band ligation in the treatment of bleeding from mild to moderate gastric varices type 1. World J Gastroenterol, 2024, 30(5):440-449. [9] Lejealle C, Valérie Paradis, Bouattour M, et al. Relationship between laennec histological subclassification of cirrhosis and clinical stage, grade of portal hypertension and liver stiffness. J Hepatol, 2020, 73(4):S781. [10] Sato A, Watanabe S, Iseki M, et al. Anticoagulation against portal vein thrombosis reduces mortality and liver cirrhosis‐related complications: A propensity score‐matched study. Hepatol Res, 2023, 53(11):1096-1104. [11] Barnes A, Cock C. Rapid reversal of hyponatraemia in a patient with non‐cirrhotic portal hypertension treated with terlipressin. Intern Med J, 2020, 50(2):254-255. [12] Lemoine CP, Superina R. Is TIPS the best treatment for non-cirrhotic adults with EPHVO and portal hypertension? Hepatology, 2022, 76(2):32386. [13] Roncati L, Manenti A, Gasparri P, et al. Portopulmonary hypertension correlated with portal vein overload. Ann Vasc Surg, 2020, 65(5):e300-e301. [14] Tripathi D, Stanley AJ, Hayes PC, et al. Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension. Gut, 2020, 69(7):1173-1192. [15] Simbrunner B, Marculescu R, Scheiner B, et al. Non‐invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease. Liver Int, 2020, 40(7):1713-1724. [16] Zheng D, Yu J, Li H, et al. Effects of transjugular intrahepatic portosystemic shunt treatment of patients with liver cirrhosis and portal hypertension: Case series.Medicine, 2021, 100(27):e26610. [17] Anand U, Kumar R, Priyadarshi R. Proximal splenorenal shunt as a secondary prophylaxis for isolated gastric bleeding in patients with non-cirrhotic portal hypertension: a report from a single-center case-series. J Hepatol, 2020, 73(3):S281-S285. [18] Jothimani D, Rela M, Kamath PS. Livercirrhosis and portal hypertension: How to deal with esophageal varices? Med Clin North Am, 2023, 107(3):491-504. [19] Tedeschi M, Ciacio O, Golse N, et al. Porto-caval shunt is a salvage manoeuvre to reduce de novo portal hypertension after major hepatectomy. HPB, 2021, 23(1):S166. [20] 汪昱,董科.改良腹腔镜脾脏切除+贲门周围血管离断术在肝硬化合并门静脉高压症中的应用研究.中华普外科手术学杂志:电子版, 2021, 15(1):65-68. |